Safety and immunogenicity of high-dose quadrivalent influenza vaccine in adults ≥65 years of age: A phase 3 randomized clinical trial von Chang, Lee-Jah, Meng, Ya, Janosczyk, Helene, Landolfi, Victoria, Talbot, H. Keipp

Volltext

160. Safety and Immunogenicity of Escalating Dose Formulations of High-dose Quadrivalent Influenza Vaccine in Children 6 Months Through < 18 Years of Age von Chang, Leejah, Anderson, Evan J, Jeanfreau, Robert, He, Ying, Hicks, Bryony, Shrestha, Anju, Pandey, Aseem, Khoury, Rawia, De Bruijn, Iris, Landolfi, Victoria

Volltext

Automated Imaging and Analysis of the Hemagglutination Inhibition Assay von Nguyen, Michael, Fries, Katherine, Khoury, Rawia, Zheng, Lingyi, Hu, Branda, Hildreth, Stephen W., Parkhill, Robert, Warren, William

Volltext

Immunogenicity and safety of high-dose quadrivalent influenza vaccine in Japanese adults ≥65 years of age: a randomized controlled clinical trial von Sanchez, Leilani, Matsuoka, Osamu, Inoue, Satoshi, Inoue, Takahiro, Meng, Ya, Nakama, Takahiro, Kato, Kumiko, Pandey, Aseem, Chang, Lee-Jah

Volltext

PV Units Accommodation Strategy In Baghdad M.V Distribution Feeder von Al-Rawia, Azhar M., Aliasb, Qais M.

Volltext